Sources | Names Used |
---|---|
CTRPv2 | erlotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | erlotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RP11-529K1.3 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
mRNA | TTC25 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
mRNA | MARK4 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
mRNA | SH3GLB1 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
mRNA | MTMR8 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
mRNA | WHSC1L1 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
mRNA | MTNR1A | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
mRNA | FAM72D | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
mRNA | OR11H6 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
mRNA | PI3 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |